New study aims to crack the code of autoimmune diseases

NCT ID NCT04902807

Recruiting now Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to create a tool that doctors can use to personalize care for patients with autoimmunity and inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a tool that helps doctors diagnose and choose treatments for autoimmune diseases more accurately.
What could go wrong: This is an observational study, not testing a treatment. It may not directly improve patient outcomes, and the tool may take years to develop and validate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APECED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disease autoimmune enteropathy autoimmune hemolytic anemia autoimmune hepatitis autoimmune lymphoproliferative syndrome autoimmune lymphoproliferative syndrome type 4 autoimmune polyendocrine syndrome type 1 autoimmune thrombocytopenia BENTA disease combined immunodeficiency Epstein-Barr virus-associated lymphoproliferative disorder Evans syndrome hemophagocytic syndrome hereditary hemophagocytic lymphohistiocytosis immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome immunodeficiency 32B inborn error of immunity inflammatory bowel disease juvenile idiopathic arthritis Lymphohistiocytosis, Hemophagocytic Polyendocrinopathies, Autoimmune Primary Immunodeficiency Diseases Purpura, Thrombocytopenic, Idiopathic systemic lupus erythematosus type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APECED AUTOIMMUNE ANEMIA AUTOIMMUNE CYTOPENIA AUTOIMMUNE DIABETES AUTOIMMUNE DISEASES AUTOIMMUNE HEPATITIS AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME AUTOIMMUNE RHEUMATOLOGIC DISEASE AUTOIMMUNE THROMBOCYTOPENIA BENTA COMBINED IMMUNODEFICIENCY EBV LYMPHOPROLIFERATION ENTEROPATHY, AUTOIMMUNE HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSES IBD IPEX JUVENILE IDIOPATHIC ARTHRITIS PRIMARY IMMUNODEFICIENCY RAS-ASSOCIATED AUTOIMMUNE LEUCOPROLIFERATIVE DISEASE SYSTEMIC LUPUS ERYTHEMATOSUS

New study aims to crack the code of autoimmune diseases

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions